CVS Health (NYSE:CVS) Upgraded by Deutsche Bank Aktiengesellschaft to “Buy” Rating

CVS Health (NYSE:CVS) was upgraded by Deutsche Bank Aktiengesellschaft from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday,Briefing.com Automated Import reports. The firm presently has a $66.00 target price on the pharmacy operator’s stock. Deutsche Bank Aktiengesellschaft’s price target suggests a potential upside of 11.73% from the stock’s current price.

Other analysts have also issued reports about the stock. StockNews.com lowered shares of CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Truist Financial restated a “buy” rating and issued a $67.00 price objective (down from $76.00) on shares of CVS Health in a report on Wednesday, November 20th. Barclays cut their target price on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research note on Thursday, November 7th. Royal Bank of Canada decreased their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research note on Friday, November 15th. Finally, TD Cowen lifted their price objective on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 25th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $70.50.

CVS Health Price Performance

CVS opened at $59.07 on Tuesday. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company has a market cap of $74.33 billion, a price-to-earnings ratio of 14.99, a price-to-earnings-growth ratio of 1.02 and a beta of 0.54. The stock has a fifty day simple moving average of $59.36 and a two-hundred day simple moving average of $58.77. CVS Health has a 12-month low of $52.71 and a 12-month high of $83.25.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s revenue was up 6.3% on a year-over-year basis. During the same period last year, the company posted $2.21 EPS. Research analysts predict that CVS Health will post 5.37 earnings per share for the current fiscal year.

Institutional Trading of CVS Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Pzena Investment Management LLC lifted its stake in shares of CVS Health by 132.9% during the 2nd quarter. Pzena Investment Management LLC now owns 12,936,388 shares of the pharmacy operator’s stock valued at $764,023,000 after buying an additional 7,382,931 shares in the last quarter. Hotchkis & Wiley Capital Management LLC boosted its stake in shares of CVS Health by 34.8% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator’s stock worth $748,085,000 after acquiring an additional 3,071,613 shares during the period. State Street Corp grew its position in shares of CVS Health by 3.6% during the third quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator’s stock worth $3,554,475,000 after purchasing an additional 1,989,066 shares in the last quarter. TOMS Capital Investment Management LP bought a new stake in CVS Health during the 3rd quarter valued at approximately $121,987,000. Finally, Pathway Financial Advisers LLC lifted its holdings in CVS Health by 5,864.2% in the 3rd quarter. Pathway Financial Advisers LLC now owns 1,730,343 shares of the pharmacy operator’s stock worth $108,804,000 after purchasing an additional 1,701,331 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.